During the second half of 2022,
Together with veterinarians,
"The animal segment is a new market and revenue stream for us", says
"Hard to heal wounds that require prolonged treatments, increase the suffering for the animal, but also the costs for the animal owner. In worst case, it can lead to amputation or to having to put the animal down."
Hard to heal wounds are a reality in animal health, as well as in the human care. Wounds can be caused by everything from shards of glass and other sharp objects, to fights and bites and are also linked to diabetes. Healing can be made more difficult by bacteria and dirt from the outside or the animal licking the wound.
THIS IS CHLORASOLV
ChloraSolv is a debriding gel, based on a unique hypochlorite technology, which is used with very good effect on leg ulcers and diabetic foot ulcers. The gel allows the gentle removal of devitalised tissue and promotes natural wound healing.1 ChloraSolv does not damage healthy tissue and is well tolerated by the patient.
- Eliasson B, Fagerdahl AM, Jönsson A, Apelqvist J. An open single arm multicenter pilot investigation to evaluate the debriding effect of amino acid buffered hypochlorite (ChloraSolv®) on chronic wounds covered with devitalized tissue during six weeks treatment.
Journal of Wound Care (Accepted for publication).
TRADING PLACE AND CERTIFIED ADVISER:
FOR MORE INFORMATION, PLEASE CONTACT:
E-mail: karin.fischer@rlsglobal.se
Tel: +46 702 48 46 51
ABOUT
RLS's long-term vision is to be a leading research-driven platform company in wound care. The ambition is to expand to new indications through new research and development projects in areas such as burns and dermatology. To maximize market presence, RLS intends to work with partners to commercialize products globally. RLS is convinced that the company's platform technology and its unique features will help many patients around the world. Read more at www.rls.global
https://news.cision.com/rls-global-ab/r/rls-global-introduces-chlorasolv-in-the-veterinary-care-segment-in-scandinavia,c3577470
(c) 2022 Cision. All rights reserved., source